Aveanna director plans $3.2M stock sale

Aveanna Healthcare Holdings, Inc. (AVAH) received a Form 144 notice indicating that director Erica G. Schwartz intends to sell up to 230,343 shares of Aveanna common stock under Rule 144.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. (AVAH) received a Form 144 notice indicating that director Erica G. Schwartz intends to sell up to 230,343 shares of Aveanna common stock under Rule 144. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC, has an approximate aggregate market value of $3,224,802.00 and references Aveanna common shares outstanding of 218,219,696. The shares derive from multiple restricted stock awards granted between January 2023 and February 2025.

Key Figures

Shares proposed to be sold: 230343 shares of common stock Approximate aggregate market value: $3,224,802.00 Shares outstanding: 218,219,696 shares +5 more

8 metrics

Shares proposed to be sold 230343 shares of common stock Amount of Aveanna common stock covered by the Form 144 notice

Approximate aggregate market value $3,224,802.00 Reported value of the 230,343 Aveanna shares proposed to be sold

Shares outstanding 218,219,696 shares Aveanna common shares referenced as outstanding in the securities information section

Restricted stock grant 02/14/2026 4,677 shares Restricted stock from issuer dated 02/14/2026 listed among securities to be sold

Restricted stock grant 01/13/2023 10,509 shares Restricted stock from issuer dated 01/13/2023 listed among securities to be sold

Restricted stock grant 08/16/2023 61,611 shares Restricted stock from issuer dated 08/16/2023 listed among securities to be sold

Restricted stock grant 02/14/2024 103,175 shares Restricted stock from issuer dated 02/14/2024 listed among securities to be sold

Restricted stock grant 02/14/2025 50,371 shares Restricted stock from issuer dated 02/14/2025 listed among securities to be sold

Key Terms

Rule 144, Restricted Stock, aggregate market value, NASDAQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 02/14/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 230343 | 3224802.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

NASDAQ market

"218219696 | 08/27/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for AVAH disclose about planned share sales?

The filing states that director Erica G. Schwartz intends to sell up to 230,343 shares of Aveanna Healthcare Holdings, Inc. common stock under Rule 144, with an approximate aggregate market value of $3,224,802.00, through Morgan Stanley Smith Barney LLC.

Who is selling AVAH shares according to this Form 144 and in what capacity?

The Form 144 lists Erica G. Schwartz as the person for whose account the AVAH securities are to be sold. She is identified in the filing as a Director of Aveanna Healthcare Holdings, Inc.

How many AVAH shares are proposed to be sold and what is their value?

The notice covers a proposed sale of up to 230,343 shares of Aveanna common stock, with an approximate aggregate market value of $3,224,802.00, as reported in the Form 144 securities information section.

What is the source of the AVAH shares listed in this Form 144?

The shares are described as Common stock acquired via Restricted Stock awards from the Issuer, with individual grants including 4,677, 10,509, 61,611, 103,175, and 50,371 shares on various dates between 2023 and 2025.

What does the Form 144 say about AVAH shares outstanding?

The Form 144 references 218,219,696 Aveanna common shares as outstanding in the securities information section. This figure provides a context baseline and is separate from the 230,343 shares covered by the proposed sale notice.

On which market are the AVAH shares in this Form 144 listed?

The securities information section identifies the Aveanna Healthcare Holdings, Inc. common stock involved in the notice as traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 05:49 PM EDT Accepted by SEC EDGAR 08/27/2026 - 05:48 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001872122
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AVEANNA HEALTHCARE HOLDINGS INC.
SEC File Number	001-40362
Address of Issuer	400 INTERSTATE NORTH PARKWAY ATLANTA GEORGIA 30339
Phone	770-441-1580
Name of Person for Whose Account the Securities are To Be Sold	ERICA G SCHWARTZ
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	230343	3224802.00	218219696	08/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2026	Restricted Stock	Issuer			4677	02/14/2026	Not Applicable
Common	01/13/2023	Restricted Stock	Issuer			10509	01/13/2023	Not Applicable
Common	08/16/2023	Restricted Stock	Issuer			61611	08/16/2023	Not Applicable
Common	02/14/2024	Restricted Stock	Issuer			103175	02/14/2024	Not Applicable
Common	02/14/2025	Restricted Stock	Issuer			50371	02/14/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Erica Schwartz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)